GLI1 and mesenchymal cell neoplasm: Surgery serves as the primary treatment for GLI1-altered mesenchymal tumors, while inhibitors of the sonic hedgehog signaling pathway may offer potential targeted therapy for tumors exhibiting GLI1 activation (24, 25).